RISK STRATIFIED SEQUENTIAL TREATMENT WITH RITUXIMAB AND CHOP CHEMOTHERAPY IN B-CELL PTLD - DEFINING A NEW STANDARD OF CARE: RESULTS FROM A PROSPECTIVE INTERNATIONAL MULTICENTER TRIAL: 1322